Radioiodinated [D‐Ala2, Met 5] enkephalin

Publisher Website
Google Scholar
Abstract
125I[D‐Ala2, Met5] enkephalin with high specific activity (122–185 Ci/mmol) was prepared and purified by Sep‐Pak C18 reverse phase cartridge followed by high performance liquid chromatography (HPLC). HPLC at pH 3.0 resolved 125I[D‐Ala2, Met5] enkephalin into two fractions, which ran as a single spot in thin‐layer chromatography with the same Rf values. Alkaline hydrolysates of the HPLC‐purified fractions showed a single spot corresponding to monoiodotyrosine standard when analysed by thin‐layer chromatography. Binding kinetics of the tracer was found to approach equilibrium after 30 min at 24d̀. Scatchard analysis of the saturation equilibrium binding studies gave an equilibrium dissociation constant of 3.58 nM and the number of binding site of 30 fmol/mg protein. Enkephalin analogs were capable of displacing 125I[D‐Ala2, Met5] enkephalin binding from the rat brain plasma membrane. The effective concentration of [D‐Ala2, Met5] enkephalin and [D‐Ala2, Leu5] enkephalin for 50% inhibition of 125I[D‐Ala2, Met5] enkephalin binding was estimated to be 79 nM and 23 nM, respectively. Both substance P and gastrin tetrapeptide failed to displace the 125I[D‐Ala2, Met5] enkephalin binding to any significant extent. The 125I[d‐Ala2, Met5] enkephalin prepared by the present procedure is therefore a useful tracer. This method of preparing radioiodinated peptide may be applicable to other enkephalin analogs or neuropeptides in general.